Literature DB >> 27146627

Transcutaneous bilirubin measurement in healthy Saudi term newborns.

Mahmood D Al-Mendalawi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27146627      PMCID: PMC4880664          DOI: 10.15537/smj.2016.5.14759

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


× No keyword cloud information.
I read with interest the study by Alsaedi1 on the transcutaneous bilirubin (TcB) measurement in healthy Saudi term newborns. The author addressed that TcB measurement provided accurate estimates of total serum bilirubin (TSB) values and it can be used effectively to screen newborns for significant jaundice.1 I presume that such conclusion ought to be cautiously taken. Apart from 4 limitations addressed by the author, I presume that the following 4 points might be additionally contributory and they could cast suspicions on the accuracy of the study results and hence, the implication in the clinical setting. 1) In the methodology, the author mentioned that BiliCheck device displayed the average in micromole/l of 5 measurements from different areas of the forehead for each bilirubin.1 Recently published studies have shown that measurement of transcutaneous bilirubin on the sternum had higher accuracy as compared to serum bilirubin measurement on the forehead.2,3 2) There are numerous different transcutaneous bilirubinometers (TcBm) in the clinical setting to estimate TcB. Comparative studies have shown varied agreement of TcBm with each other and TSB.4-6 3) The author addressed that the study was conducted in the western region of Kingdom of Saudi Arabia with a population of diverse ethnic backgrounds and various degree of skin pigmentation.1 I presume that the different racial backgrounds of the studied population could alter the precision of the study results as it has been noticed that the race could affect TcB bias when measurements were carried out on the forehead, but not when they were carried out on the sternum.7 4) Better interpretation of TcB measurement in the neonatal clinical setting is based on an hour-specific, percentile-based TcB nomogram.8 To my knowledge, such nomogram is not yet constructed during the early neonatal period for Saudi neonates. Despite the aforementioned limitations, I think that TcB measurement represents a revolutionary step in the management of neonatal jaundice as it is associated with less pain related to heel prick as well as 55% reduction in blood samples taken in jaundiced term and near-term babies.9 I would like to thank Prof. Al-Mendalawi for his interest and comments on our paper. He questioned the accuracy of TcB measurement at the forehead as compared with its measurement at the sternum, the different devices used for TcB measurement and the effect of race and skin color on the accuracy of TcB measurement. First, the objective of our study was not to compare the accuracy of the site of TcB measurement neither to compare different devices of measurement of TcB. Second, there are conflicting reports regarding the accuracy of measuring TcB at forehead versus measuring it from the sternum. Even the studies which concluded that either site is superior, the difference is minute to have any clinical implications. He quoted 2 studies by Conceição etal3 and Kosorat and Khuwuthyakorn.2 Conceição et al3 reported that the correlation between TSB and TcB as measured at the forehead had better correlation when compared with TcB measurement from the sternum (r=0.704 versus r=0.653). However, the mean value of TcB measured at the sternum (9.9±2.2 mg/dL) compared to plasma levels (10.2±1.7 mg/dL), is better compared with the mean value of TcB measured at the forehead (8.6±2.0 mg/dL) (p<0.05). The correlation coefficient of measurements from either site is much less than what was reported in the literature where the correlation coefficient ranged from r=0.080 to r=0.91. It is not known whether this was due to the study population, methods used, or both. Kosorat and Khuwuthyakorn2 reported that measuring TcB from 4 sites from the forehead and 4 sites from the sternum. The correlation coefficients between TcB at forehead and TSB were significant for 2 (r=0.812), 3 (r=0.800), and 4 (r=0.800) measurements. Transcutaneous bilirubin measured at sternum also had significant correlation with TSB (r=0.829 for 2, r=0.844 for 3, and r=0.823 3 for 4 measurements). Although TcB measurement from the sternum has a better correlation, but its measurement from the forehead is more precise. Marenez et al10 reported that measurement of TcB from the forehead has better correlation with TSB than TcB measurement from the sternum (r=0841 versus r=0.794). Third, the effect of race and skin color on the accuracy of TcB measurements. We have mentioned in our discussion that BiliCheck scans the whole spectrum of visible light and automatically subtracts the beam reflected by confounding factors, such as hemoglobin, dermal thickness or melanin, and it isolates the absorption of light due to bilirubin in the capillary bed and subcutaneous tissue; therefore, calculating the concentration of bilirubin. Several studies11-13 reported that skin color and race has no effect on accuracy of TcB using BiliCheck device. Saad Alsaedi Department of PediatricsFaculty of MedicineKing Abdulaziz UniversityJeddah, Kingdom of Saudi Arabia
  12 in total

1.  Plotting transcutaneous bilirubin measurements on specific transcutaneous nomogram results in better prediction of significant hyperbilirubinemia in healthy term and near-term newborns: a pilot study.

Authors:  I Mohamed; A C Blanchard; E Delvin; J Cousineau; A Carceller
Journal:  Neonatology       Date:  2014-03-01       Impact factor: 4.035

2.  Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia.

Authors:  V K Bhutani; G R Gourley; S Adler; B Kreamer; C Dalin; L H Johnson
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

3.  Transcutaneous bilirubin measurement: a multicenter evaluation of a new device.

Authors:  F F Rubaltelli; G R Gourley; N Loskamp; N Modi; M Roth-Kleiner; A Sender; P Vert
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

4.  The value of Bilicheck as a screening tool for neonatal jaundice in term and near-term babies.

Authors:  S Samanta; M Tan; C Kissack; S Nayak; R Chittick; C W Yoxall
Journal:  Acta Paediatr       Date:  2004-11       Impact factor: 2.299

5.  Comparison of two transcutaneous bilirubinometers in term and near-term neonates.

Authors:  Serdar Umit Sarici; Esad Köklü; Oguzhan Babacan
Journal:  Neonatal Netw       Date:  2014 May-Jun

6.  Implementing and validating transcutaneous bilirubinometry for neonates.

Authors:  Lorne Holland; Kenneth Blick
Journal:  Am J Clin Pathol       Date:  2009-10       Impact factor: 2.493

7.  The accuracy of transcutaneous bilirubin measurements in neonates: a correlation study.

Authors:  Shakuntala Nanjundaswamy; Anna Petrova; Rajeev Mehta; William Bernstein; Thomas Hegyi
Journal:  Biol Neonate       Date:  2003-11-19

8.  Comparison of the transcutaneous bilirubinometers BiliCare and Minolta JM-103 in late preterm and term neonates.

Authors:  Simone Pratesi; Luca Boni; Lorenzo Tofani; Elettra Berti; Sara Sollai; Carlo Dani
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-02

9.  Accuracy of transcutaneous bilirubin measurement in term newborns.

Authors:  Shanika Kosarat; Varangthip Khuwuthyakorn
Journal:  J Med Assoc Thai       Date:  2013-02

10.  Influence of assessment site in measuring transcutaneous bilirubin.

Authors:  Cristiane Maria Conceição; Maria Fernanda Pellegrino da Silva Dornaus; Maria Aparecida Portella; Alice D Agostini Deutsch; Celso Moura Rebello
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.